**Chapter 2**

*Role of Novel Drug Delivery Vehicles in Nanobiomedicine*

characterization of aptamers.

Sciences. 2013;**110**:18460-18465

[95] Cho M, Xiao Y, Nie J, et al.

2010;**107**:15373-15378

2010;**5**:1-7

Proceedings of the National Academy of

[94] Zimmermann B, Gesell T, Chen D, et al. Monitoring genomic sequences during SELEX using high-throughput sequencing: Neutral SELEX. PLoS One.

Quantitative selection of DNA aptamers through microfluidic selection and highthroughput sequencing. Proceedings of the National Academy of Sciences.

[96] Hoon S, Zhou B, Janda KD, et al. Aptamer selection by high-throughput sequencing and informatic analysis. BioTechniques. 2011;**51**:413-416

[97] Kaur H, Bruno JG, Kumar A, Sharma TK. Aptamers in the

therapeutics and diagnostics pipelines. Theranostics. 2018;**8**:4016-4032

[98] Kanwar JR, Roy K, Maremanda NG, Subramanian K, et al. Nucleic acid-based aptamers: Applications, development and clinical trials. Current Medicinal Chemistry. 2015;**22**:2539-2557

studies. 2018;**11**:420-428. DOI: 10.1111/1751-7915.13041

[84] Hamilton S. Introduction to

Screening. 2002;**190**:169-189

[85] Cohen S, Trinka RF. Fully

screening automation. High-Throughput

automated screening systems. Methods in Molecular Biology. 2002;**190**:213-228

[87] Konthur Z. Automation of selection and engineering. In: Handbook of Therapeutic Antibodies. Weinhem: Wiley-VCH; 2007. pp. 413-431

[88] Cox JC, Ellington AD. Automated selection of anti-protein aptamers. Bioorganic & Medicinal Chemistry.

[89] Cox JC, Hayhurst A, Hesselberth J, et al. Automated selection of aptamers against protein targets translated in vitro: From gene to aptamer. Nucleic

Acids Research. 2002;**30**:e108

[90] Cox JC, Rajendran M, Riedel T, et al. Automated acquisition of aptamer sequences. Combinatorial Chemistry & High Throughput Screening.

[91] Drolet DW, Jenison RD, Smith DE, et al. A high throughput platform for systematic evolution of ligands by exponential enrichment (SELEX). Combinatorial Chemistry & High Throughput Screening. 1999;**2**:271-278

[92] Eulberg D, Buchner K, Maasch C, et al. Development of an automated in vitro selection protocol to obtain RNA-based aptamers: Identification of a biostable substance P antagonist. Nucleic Acids Research. 2005;**33**:1-10

[93] Cho M, Soo Oh S, Nie J, et al. Quantitative selection and parallel

2001;**9**:2525-2531

2002;**5**:289-299

[86] Menke KC. Unit automation in high throughput screening. Methods in Molecular Biology. 2002;**190**:195-212

**22**
